Neurologic complications of critical medical illnesses and transplantation

Current Opinion in Critical Care

Volumn 4, Issue 2, 1998, Pages 69-75

  Vespa, Paul ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0040633695     PISSN: 10705295     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075198-199804000-00001     Document Type: Article

References (80)

1. Hamel MB, Goldman L, Teno J, Lynn J, Davis RB, Harrell FE Jr, Connors AF Jr, Califf R, Kussin P, Bellamy P, et al.: Identification of comatose patients at high risk for death or severe disability. SUPPORT Investigators. Understand Prognoses and Preferences for Outcomes and Risks of Treatments. JAMA 1995, 273:1842-1848.
2. Isensee LM, Weiner LJ, Hart HG: Neurologic disorders in a medical intensive care unit: a prospective survey. J Crit Care 1989, 4:208-210.
3. Bleck TP, Smith MC, Pierre-Louis JC, Jares JJ, Murray J, Hansen C: Neurologic complications of critical medical illnesses. Crit Care Med 1993, 21:98-103.
4. Witt NJ, Zochodne DW, Botlon CF: Peripheral nerve function in sepsis and multiple organ failure. Chest 1991, 99:176-184.
5. Young GB, Bolton CF, Austin TW: The encephalopathy associated with septic illness. Clin Invest Med 1990, 13:297-304.
6. Osler W: The Principles and Practice of Medicine. New York: D. Appelton;1892:114-118.
7. Bolton CF, Young GB, Zochodne DW: The neurological complications of sepsis. Ann Neurol 1993, 33:94-100.
8. Eidelman LA, Putterman D, Putterman C, Sprung CL: The spectrum of septic encephalopathy: definitions, etiologies, and mortalities. JAMA 1996, 275:470-473. This is a recent assessment of the epidemiology of septic encephalopathy from an intensivist's perspective.
9. Castella X, Gilabert J, Torner F, Torres C: Mortality prediction models in intensive care: acute physiology and chronic health evaluation II and mortality prediction model compared. Crit Care Med 1991, 19:191-197.
10. Widjicks EFM, Stevens, et al.: The role of hypotension in septic encephalopathy following surgical procedures. Arch Neurol 1992, 49:653-656.
11. Pine RW, Wertz MJ, Lennard ES, Dellinger EP: Determinants of organ malfunction or death in patients with intra-abdominal sepsis. Arch Surg 1983, 118:242-249.
12. Bitsch A, Nau R, Hilgers RA, Verheggen R, Werner G, Prange HW: Focal neurologic deficits in infective endocarditis and other septic diseases. Acta Neurol Scand 1996, 94:279-286.
13. Pendelbury WW, Perl DP, Munoz DG: Multiple microabscesses in the central nervous system. J Neuropathol Exp Neurol 1989, 48:290-300.
14. Jackson AC, Gilber JJ, Young GB, Bolton CF: The encephalopathy of sepsis. Can J Neurol Sci 1985, 12:303-307.
15. Sprung CL, Cerra FB, Freund HR: Amino acid alterations and encephalopathy in the sepsis syndrome. Crit Care Med 1991, 19:753-757.
16. Dammann O, Leviton A: Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 1997, 42:1-8.
17. Zhan RZ, Rujiwara N, Shimoji K: Regionally different elevation of intracellular free calcium in hippocampus of septic rat brain. Shock 1996, 6:293-297.
18. Kadoi Y, Saito S, Kunimoto F, Imai, Fujita T: Impairment of the brain beta-adrenergic system during experimental endotoxemia. J Surg Res 1996, 61:496-502.
19. Bowton DL, Bertels NH, Prough DS, Stump DA: Cerebral blood flow is reduced in patients with sepsis syndrome. Crit Care Med 1989, 17:399-403.
20. Berre J, De Backer D, Moraine JJ, Melot C, Kahn RJ, Vincent JL: Dobutamine increases cerebral blood flow velocity and jugular bulb hemoglobin saturation in septic patients. Crit Care Med 1997, 25:392-398. This is a recent publication indicating that cerebral blood flow and oxidative metabolism is dynamic in septic patients and outlines a practical means of assessing the ideal mean arterial pressure.
21. Straver JS, Keunen RWM, Stam CJ, Tavy DLJ, De Ruiter GR, Smith SJ, Thijs LG: Transcranial Doppler and systemic hemodynamic studies in septic shock. Neurol Res 1996, 18:313-319.
22. Matta BF, Stow PJ: Sepsis-induced vasoparalysis does not involve the cerebral vasculature: indirect evidence from autoregulation and carbon dioxide reactivity studies. Br J Anaesth 1996, 76:790-794.
23. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, Pessin MS, Lamy C, Mas JL, Caplan RL: A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996, 334:494-500.
24. Tasker RC, Boyd SG, Harden A, Kendall B, Harding BN, Matthew DJ: The clinical significance of seizures in critically ill young infants requiring intensive care. Neuropediatrics 1991, 22:129-138.
25. Guess HA, Resseguie U, Melton LJ, Kurland LT, Lydick EG, Aksamit AJ, Wilson WR: Factors predictive of seizures among intensive care unit patients with gram-negative infections. Epilepsia 1990, 31:567-573.
26. Young GB, Bolton CF, Austin TW: The EEG in septic encephalopathy. J Clin Neurophysiol 1992, 9:145-152.
27. Hockaday JM, Potts F, Boazzi A, Schwab RS: Electroencephalographic changes in acute cerebral anoxia from cardiac or respiratory arrest. Electroencephal Clin Neurophysiol 1965, 18:575-586.
28. Bricolo A, Trues S, Facial F, Odorizzi F, Sciaretta G, Erculiani P: Clinical application of compressed spectral array in long term EEG monitoring of comatose patients. Electroencephalogr Clin Neurophysiol 1978, 45:211-225.
29. Synek VM: Prognostically important EEG coma patterns in diffuse anoxic and traumatic encephalopathies in adults. J Clin Neurophysiol 1988, 5:161-174.
30. Young GB, Jordan KG, Doig GS: An assessment of nonconvulsive seizures in the intensive care unit using continuous EEG monitoring: an investigation of variables associated with mortality. Neurology 1996, 47:83-89.
31. Vespa PM, Bergsneider M, Martin NA, Hovda D, Kelly D, Shalmon E, Becker D: Regional and global glucose metabolism after traumatic brain injury: influence of seizures. Neurology 1995, 47:S781.
32. Vespa PM, Nuwer MR, Juhasz C, Alexander M, Martin N, Becker DP: Early detection of vasospasm after Subarachnoid Hemorrhage using continuous Quantitative EEG. Electroencephalogr Clin Neurophysiol 1998, 103:607-615.
33. Estol CJ, Lopez O, Brenner RP, Martinez AJ: Seizures after liver transplantation: a clinicopathologic study. Neurology 1989, 39:1297-1301.
34. Wijdicks EF, Plevak DJ, Rakela J, Wiesner RH: Clinical and radiologic features of cerebral edema in fulminant hepatic failure. Mayo Clin Proc 1995, 70:119-124.
35. Gazzard BG, Portmann B, Murray-Lyon IM, Williams R: Causes of death in fulminant hepatic failure and relationship to quantitative histological assessment of parenchymal damage. Quart J Med 1975, 44:615-626.
36. Wendon JA, Harrison PM, Keays R, Williams R: Cerebral blood flow and metabolism in fulminant liver failure. Hepatology 1994, 19:1407-1413.
37. 2 reactivity in fulminant hepatic failure. J Cereb Blood Flow Metabol 1995, 15:329-335.
38. Larsen FS, Hansen BA, Ejlersen E, Secher NH, Clemmesen JO, Tygstrup N, Knudsen GM: Cerebral blood flow, oxygen metabolism and transcranial Doppler sonography during high-volume plasmapheresis in fulminant hepatic failure. Europ J Gastroenter Hepatol 1996, 8:261-265.
39. Macdonald GA, Frey KA, Agranoff BW, Minoshima S, Koeppe RA, Kuhl DE, Shulkin BL, Lucey MR: Cerebral benzodiazepine receptor binding in vivo in patients with recurrent hepatic encephalopathy. Hepatology 1997, 26:277-282.
40. Strauss G, Adel Hansen B, Kirkegaard P, Rasmussen A, Hjortrup A, Larsen FS: Liver function, cerebral blood flow autoregulation and hepatic encephalopathy in fulminant hepatic failure. Hepatology 1997, 25:837-839.
41. Basile AS, Saito K, Li, Li Y, Heyes MP: The relationship between plasma and brain quinolinic acid levels and the severity of hepatic encephalopathy in animal models of fulminant hepatic failure. J Neurochem 1995, 64:2607-2614.
42. Davies MH, Mutimer D, Lowes J, Elias E, Neuberger J: Recovery despite impaired cerebral perfusion in fulminant hepatic failure. Lancet 1994, 343:1329-1330.
43. Ejlersen E, Larsen FS, Pott F, Gyrtrup HJ, Kirkegaard P, Secher NH: Hepatectomy corrects cerebral hyperperfusion in fulminant hepatic failure. Transplant Proc 1994, 26:1794-1795.
44. Watanabe FD, et al.: Clinical experience with bioartificial liver in the treatment of severe liver failure: a phase I clinical trial. Ann Surgery 1997, 225:484-491.
45. Yoshiba M, Yoshiba M, Inoue K, Sekiyama K, Koh I: Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure. Artificial Organs 1996, 20:1169-1172.
46. Okamoto K, et al.: Prolonged artificial liver support in a child with fulminant hepatic failure. Asaio J 1996, 42:233-235.
47. Larsen FS, Ejlersen E, Hansen BA, Knudsen GM, Tygstrup N, Secher NH: Functional loss of cerebral blood flow autoregulatlon in patients with fulminant hepatic failure. J Hepatol 1995, 23:212-217.
48. Adams DH, Ponsford S, Gunson B, Boon A, Honigserger L, Williams A, Buckels J, Elias E, McMaster P: Neurological complications following liver transplantation. Lancet 1987, 1:949-951.
49. Vogt DP, Lederman RJ, Carey WD, Broughan TA: Neurologic complications of liver transplantation. Transplantation 1988, 45:1057-1061.
50. Stein DP, Lederman RJ, Vogt DP, Carey WD, Broughan TA: Neurological complications following liver transplantation. Ann Neurol 1992, 31:644-649.
51. Pujol A, Graus F, Rimola A, Betran J, Garcia-Valdecasas JC, Navasa M, Grande L, Galofre J, Rodes J, Tolosa E: Predictive factors of in-hospital CNS complications following liver transplantation. Neurology 1994, 44:1226-1230.
52. Moreno E, Gómez SR, Gonzalez I, Loinaz C, Garcia I, Perez A, Palomo C, Alvarado A, Maffettone V, Perez-Cerda F: Neurologic complications in liver transplantation. Acta Neurol Scand 1993, 87:25-31.
53. Anders KH, Becker PS, Holden JK, Sharer LR, Cornford ME, Hansen LA, Hamilton R, Vinters HV: Multifocal necrotizing leukoencephalopathy with pontine predilection in immunosuppressed patients: a clinicopathologic review of 16 cases. Hum Pathol 1993, 24:897-904.
54. Vogt DP, Lederman RJ, Carey WD, Brougham TA: Neurologic complications of liver transplantation. Transplantation 1988; 45:1057-1061.
55. Ferreiro JA, Robert MA, Townsend J, Vinters HV: Neuropathologic findings after liver transplantation. Acta Neuropathol 1992, 84:1-14.
56. Wijdicks EF: Plevak DJ, Wiesner RH, Steers JL: Causes and outcome of siezures in liver transplant recipients. Neurology 1996, 47:1523-1525.
57. Wszolek ZK, Steg RE: Seizures and orthotopic liver transplantation. Seizure 1997, 6:31-39.
58. de Groen PC, Aksamit AJ, Rakela J, Forbes GS, Krom RA: Central nervous system toxicity after liver transplantation: the role of cyclosporine and cholesterol. N Engl J Med 1987, 317:861-866.
59. Steg RE, Wszolek ZK: Electroencephalographic abnormalities in liver transplant recipients: practical considerations and review. J Clin Neurophysiol 1996, 13:60-68. This article provides an outline of raw EEG abnormalities and a review of the literature.
60. Rubin AM, Kang H: Cerebral blindness and encephalopathy with cyclosporin A toxicity. Neurology 1987, 37:1072-1076.
61. Jansen O, Krieger D, Krieger S, Sartor K: Cortical hyperintensity on proton density-weighted images: an MR sign of cyclosporine-related encephalopathy. Am J Neuroradiol 1996, 17:337-344.
62. Lane RJM, Roche SW, Leung AAW, Greco A, Lange LS: Cyclosporin neurotoxicity in cardiac transplant recipients. J Neurol Neurosurg Psychiatry 1988, 51:1434-1437.
63. Burkhalter EL, Starzl TE, Van Thiel DH: Severe neurological complications following orthotopic liver transplantation in patients receiving FK 506 and prednisone. J Hepatol 1994, 21:572-577.
64. Pirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo RS: A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Transplantation 1997, 63:977-983.
65. Sloane JP, Lwin KY, Bgore ME, Powles RL, Smith JF: Disturbance of the blood brain barrier after bone-marrow transplantation. Lancet 1985, ii:280-281.
66. Torre-Cisneros J, Lopez OL, Kusne S, Martinez AJ, Starzl TE, Simmons RL, Martin M: CNS aspergillosis in organ transplantation: a clinicopathological study. J Neurol Neurosurg Psychiatry 1993, 56:188-193.
67. Mikhael MA, Rushovich AM, Ciric I: Magnetic resonance imaging of cerebral aspergillosis. Comput Rad 1985, 9:85-89.
68. Schwechheimer K, Hashemian A: Neuropathologic findings after organ transplantation: an autopsy study. Gen Diagn Pathol 1995, 141:35-39.
69. Bolton CF, Young GB: Neurological complications in critically ill patients. In Neurology and General Medicine. Edited by Aminoff, MJ. New York: Churchill Livingstone; 1989; 713-729.
70. Zochodne DW, Ramsay DA, Saly V, Shelley S, Moffatt S: Acute necrotizing myopathy of intensive care: electrophysiological studies. Muscle Nerve 1994, 17:285-292.
71. Bolton CF, Lavery DA, Brown JD: Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry 1984, 47:1223-1231.
72. Barat M, Brochet B, Vital C: Polyneuropathles au cours de sejours prolonges en renanimation. Rev Neurol 1987, 143:823-831.
73. Berek K, Margreiter J, Willeit J, Berek A, Schmutzhard E, Mutz NJ: Polyneuropathies in critically ill patients: a prospective evaluation. Intensive Care Medicine 1996, 22:849-855.
74. Hund E, Genzwurker H, Bohrer H, Jakob H, Thiele R, Hacke W: Predominant involvement of motor fibres in patients with critical illness polyneuropathy. Br J Anesth 1997, 78:274-278.
75. Bolton CF: Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit Care Med 1996, 24:1408-1416.
76. Gutmann L, Blumenthal D, Gutmann L, Schochet SS: Acute type II myofiber atrophy in critical illness. Neurology 1996, 46:819-821.
77. Jordan KG: Continuous EEG and evoked potential monitoring in the neuroscience intensive care unit. J Clin Neurophysiol 1993, 10:445-475.
78. Chiappa KH, Hoch DB: Electrophysiologic monitoring. In Neurological and Neurosurgical Intensive Care, edn 3. Edited by Ropper AH. New York: Raven Press; 1993:147-183.
79. Nuwer MR: EEG and evoked potentials-monitoring cerebral function in the neurosurgical intensive care unit. Neurosurg Clin North Amer 1994, 5:647-659.
80. Vespa PM, Nuwer MR: Neurologic monitoring in the ICU. Clin Pulm Med 1997, 4:85-92.